trending Market Intelligence /marketintelligence/en/news-insights/trending/6aajoijwzzm-rgafbesrbg2 content esgSubNav
In This List

Verastem Oncology plans to raise $43M through common stock offering

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Verastem Oncology plans to raise $43M through common stock offering

Verastem Inc. plans to raise about $43.0 million through an offering of 7,166,666 of its common shares at $6.00 apiece.

The shares were offered to funds managed by healthcare-focused private equity firm Consonance Capital Partners LP.

The offering is expected to close June 18, subject to customary closing conditions.

Needham, Mass.-based Verastem is a biopharmaceutical company which focuses on discovering and developing cancer drugs.